Work

Combining an amyloid‐beta (Aβ) cleaving enzyme inhibitor with a γ‐secretase modulator results in an additive reduction of Aβ production

Year: 2014

Type: article

Source: FEBS Journal

DOI: 10.1111/febs.13103

Authors: Kia Strömberg, Susanna Eketjäll, Biljana Georgievska, Karin Tunblad, Kristina Eliason, Fredrik Olsson, Ann‐Cathrin Radesäter, Rebecka Klintenberg, Per I. Arvidsson, Stefan von Berg, Johanna Fälting, Richard F. Cowburn, Michael Dabrowski

Institutions: AstraZeneca (Sweden), Science for Life Laboratory

Language: English

Topic: Alzheimer's disease research and treatments

Subfield: Cellular and Molecular Neuroscience

Field: Neuroscience

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: AstraZeneca

OpenAlex ID: W1970004454

FWCI: 1.101

Cites: 40

Cited by: 23

Related to: 10